Cautiously Optimistic :: Biogen Inc., (NASDAQ: BIIB)


On Tuesday, November 10, 2020, the Company, Biogen Inc., BIIB stock construct a change of 0.03 percent (Gain) in a total of its share price and having its trading value $236.34, which belongs to Healthcare sector and Drug Manufacturers – General industry. The company’s Market capitalization was $36.37B with the total Outstanding Shares of 156.90M.


P/S, P/E, P/B & P/C values of (NASDAQ: BIIB):


Biogen Inc. institutional ownership is standing at 90.5 percent, while insider ownership is 0.1 percent. As of now, BIIB has a P/S, P/E and, P/B values of 2.55, 7.82, and 3.45 respectively. Its P/Cash is valued at 10.16.


The stock SMA50 is now at -14.24 percent. In looking, the SMA 200 we see that the stock has seen a -19.04 percent. The Company’s net profit margin for the 12 months at 35.6 percent. Comparatively, the gazes have a Gross margin of 87.6 percent.

Profitability ratios:


Looking into the profitability ratios of BIIB stock, an investor will find its ROE, ROA, ROI standing at 42.4 percent, 19.6 percent and, 30.5 percent, respectively.

Beta Factor:


A beta factor is used to measure the volatility of the stock. The stock remaining at 13.57 percent volatile for the week and 5.29 percent for the month.

Gross / Operating Margins of BIIB:


It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 87.6 percent & Operating Margin seen at 46.7 percent.

Target Price:


Target Price informs the investors, a stock survey at which a trader is willing to buy or sell a stock. At which a trader projects that a buyer will buy a product. The company Biogen Inc. recorded it at $313.6.

Historical Performance In The News:


Taking a look at the performance of Biogen Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at -5.08 percent, resulting in a performance for the month at -17.52 percent.

Therefore, the stated figure displays a quarterly performance of -18.49 percent, bringing six-month performance to -26.09 percent and year to date performance of -20.35 percent. As of now, Biogen Inc. has a P/S, P/E and, P/B values of 2.55, 7.82, and 3.45 respectively. Its P/Cash is valued at 10.16.

Earnings per Share Details of Biogen Inc.:


The EPS of BIIB is strolling at 30.21, measuring its EPS growth this year at 44.8 percent. As a result, the company has an EPS growth of -24.48 percent for the approaching year.


EPS growth is an important number as it gives a suggestion of the future prospects of a company. It is usually expressed as a percentage and is then referred to as the EPS growth rate. Growth in EPS is an important measure of administration performance because it shows how much money the company is making for its investors or shareholders, not only because of changes in profit but also after all the effects of issuance of new shares (this is especially important when the growth comes as a result of acquisition).

Given the importance of identifying companies that will ensure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.


We can’t have enough maintenance the once will always reflect the difficult, but logically stocks that have grown earnings per allowance strongly in the subsequent to are a fine bet to continue to take effect as a result.